...
首页> 外文期刊>Journal of Clinical Microbiology >Detection of Toxigenic Clostridium difficile: Comparison of the Cell Culture Neutralization, Xpert C. difficile, Xpert C. difficile/Epi, and Illumigene C. difficile Assays
【24h】

Detection of Toxigenic Clostridium difficile: Comparison of the Cell Culture Neutralization, Xpert C. difficile, Xpert C. difficile/Epi, and Illumigene C. difficile Assays

机译:产毒艰难梭菌的检测:细胞培养中和,Xpert艰难梭菌,Xpert艰难梭菌/ Epi和Illumigene艰难梭菌检测方法的比较

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Clostridium difficile is the most important cause of nosocomial diarrhea. Several laboratory techniques are available to detect C. difficile toxins or the genes that encode them in fecal samples. We evaluated the Xpert C. difficile and Xpert C. difficile/Epi (Cepheid, CA) that detect the toxin B gene (tcdB) and tcdB, cdt, and a deletion in tcdC associated with the 027/NAP1/BI strain, respectively, by real-time PCR, and the Illumigene C. difficile (Meridian Bioscience, Inc.) that detects the toxin A gene (tcdA) by loop-mediated isothermal amplification in stool specimens. Toxigenic culture was used as the reference method for discrepant stool specimens. Two hundred prospective and fifty retrospective diarrheal stool specimens were tested simultaneously by the cell cytotoxin neutralization assay (CCNA) and the Xpert C. difficile, Xpert C. difficile/Epi, and Illumigene C. difficile assays. Of the 200 prospective stools tested, 10.5% (n = 23) were determined to be positive by CCNA, 17.5% (n = 35) were determined to be positive by Illumigene C. difficile, and 21.5% (n = 43) were determined to be positive by Xpert C. difficile and Xpert C. difficile/Epi. Of the 50 retrospective stools, previously determined to be positive by CCNA, 94% (n = 47) were determined to be positive by Illumigene C. difficile and 100% (n = 50) were determined to be positive by Xpert C. difficile and Xpert C. difficile/Epi. Of the 11 discrepant results (i.e., negative by Illumigene C. difficile but positive by Xpert C. difficile and Xpert C. difficile/Epi), all were determined to be positive by the toxigenic culture. A total of 21% of the isolates were presumptively identified by the Xpert C. difficile/Epi as the 027/NAP1/BI strain. The Xpert C. difficile and Xpert C. difficile/Epi assays were the most sensitive, rapid, and easy-to use assays for the detection of toxigenic C. difficile in stool specimens.
机译:艰难梭菌是医院腹泻的最重要原因。有几种实验室技术可用于检测粪便样品中的艰难梭菌毒素或编码它们的基因。我们评估了检测毒素B基因( tcdB )和 tcdB cdt <的Xpert艰难梭菌和Xpert艰难梭菌/ Epi(加利福尼亚Cepheid) / em>,并分别通过实时PCR和与Illumigene C. difficile(Meridian Bioscience,Inc.)检测的与027 / NAP1 / BI菌株相关的 tcdC 中的缺失。通过粪便标本中的环介导的等温扩增获得毒素A基因( tcdA )。产毒培养物用作差异粪便标本的参考方法。通过细胞毒素中和测定法(CCNA)和艰难梭菌Xpert,艰难梭菌/ Epi和艰难梭菌Illumigene艰难梭菌测定,同时测试了200例前瞻性和50例腹泻性大便标本。在CCNA中,在200个预期的粪便中,有10.5%( n = 23)为阳性,由Illumigene确定为17.5%( n = 35)为阳性Xpert艰难梭菌和Xpert艰难梭菌/ Epi确定艰难梭菌为21.5%( n = 43)为阳性。在先前通过CCNA确定为阳性的50例回顾性粪便中,艰难梭菌检出的94%( n = 47)和100%( n )为阳性Xpert C. difficile和Xpert C. difficile / Epi确定为50。在11个不一致的结果中(即,艰难梭菌阴性,而Xpert艰难梭菌和Xpert艰难梭菌/ Epi阳性),所有产毒培养都确定为阳性。 Xpert艰难梭菌/ Epi推测总共鉴定出21%的分离株为027 / NAP1 / BI菌株。 Xpert艰难梭菌和Xpert艰难梭菌/ Epi检测是检测粪便标本中艰难梭菌的最灵敏,快速且易于使用的检测方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号